05 Jun BizTimes Milwaukee: TAI Diagnostics launches series B funding round
Wauwatosa-based biotech firm TAI Diagnostics recently launched a Series B funding round in hopes of raising $15 million to $20 million, according to chief executive officer Frank Langley.
Previously, the company had raised a little more than $25 million in outside funding.
TAI provides non-invasive diagnostic tests to monitor the health of transplanted organs in the patients that have received them.
Read the full article here.